Print this page | Back to Web Page

Abbott Acquires Piramal's Healthcare Solutions Business

PHS May 21, 2010
Abbott announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for an up-front payment of $2.12 billion, plus $400 million annually for the next four years, giving Abbott the No. 1 position in the Indian pharmaceutical market. This further accelerates Abbott's emerging markets growth following the recent acquisition of Solvay Pharmaceuticals and announcements last week of Abbott's collaboration with Zydus Cadila as well as the creation of a new stand-alone Established Products Division to focus on expanding the global markets for its leading branded generics portfolio. More »

Press Release: May 21, 2010
Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business
Abbott India Fact Sheet (PDF)
Abbott-Piramal Healthcare Solutions Overview (PDF)
Images
- Abbott headquarters facility in Mumbai (1395x1417 pixels)
- Abbott pharmaceutical manufacturing facility in Goa (3872x2592 pixels)

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.